D. Moreno Muñoz

One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study

L. Cabezón-Gutiérrez, Almudena Sanz-Yagüe, R. Chicas-Sett, 2021, BMJ supportive & palliative care.

Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis

B. Soler López, L. Cabezón Gutiérrez, J. F. Fírvida Pérez, 2020, BMJ Supportive & Palliative Care.

Changing the History of Prostate Cancer with New Targeted Therapies

F. Couñago, S. Hernando Polo, Adriana Carolina Rosero Rodríguez, 2021, Biomedicines.

Fecal calprotectin as a predictor of gastrointestinal immune-related adverse events (CF-19): A prospective study.

E. Pérez Fernández, S. Hernando Polo, A. González López, 2021, F1000Research.

Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study

A. M. Muñoz Martín, P. Jiménez-Fonseca, A. Carmona-Bayonas, 2023, PloS one.

Prediction of serious complications in patients with cancer and pulmonary thromboembolism: validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO Study

A. M. Muñoz Martín, M. Sánchez Cánovas, A. Fernández Montes, 2022, medRxiv.

85P Correlation between nCOUNTER PAM-50 assay and three IHC-based surrogate intrinsic breast cancer subtype classifiers: A real-world study

M. Cebollero, I. Márquez-Rodas, J. G. García Sáenz, 2022, Annals of Oncology.

Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study.

J. García-Saenz, M. Cebollero, I. Márquez-Rodas, 2023, Breast Cancer Research and Treatment.